JAMES WOLFENBARGER: Open Payments
NPI 1265421507 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,247 in 51 payments from 29 companies in 2025. Trend: 2023 $1,166 · 2024 $1,115 · 2025 $1,247
Food & beverage: $1,178Education: $68
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $209 |
| AstraZeneca Pharmaceuticals LP | 2 | $98 |
| Daiichi Sankyo Inc. | 4 | $91 |
| Novartis Pharmaceuticals Corporation | 4 | $87 |
| GENZYME CORPORATION | 3 | $79 |
| Regeneron Healthcare Solutions, Inc. | 3 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
| Merck Sharp & Dohme LLC | 2 | $52 |
| Exelixis Inc. | 2 | $51 |
| Novocure Inc. | 2 | $33 |
Products named: RYBREVANT, IMFINZI, KISQALI, LIBTAYO, NINLARO, CABOMETYX, TALVEY, Enhertu.
Industry payments across TN — which companies pay providers there.
